Cholesterol Common in Diabetes II Patients Found to Increase Heart Disease
A newly discovered form of cholesterol called MGmin-low-density lipoprotein has just been observed to greatly increase the risk of heart disease. This observation was made by scientists from the University of Warwick who dubbed the newly discovered form of cholesterol as ultra-bad’ as it increases the risk of heart disease more than the previously known forms of cholesterol. This type of cholesterol has been noticed to be of higher occurrence in people with type 2 diabetes and the elderly.
The research that led to the discovery of the relation between MGmin-low-density lipoprotein was funded by the British Heart Foundation. The scientists found that this cholesterol was many more times stickier than the usual low density lipids. It thus easily sticks to the arteries’ wall which then leads to the formation of the plaques that cause coronary heart disease (CHD).
According to the coronary heart statistics of Scarborough, more than 88,000 people in the UK die from CHD every single year.
Due to the evidence that this cholesterol is more common in those with type 2 diabetes, it was also consequently observed that those who were on the widely prescribed anti diabetic drug metformin were at less risk of dying from heart disease. This has led the scientists to begin research on how to use metformin to reduce the risk of heart disease. Metformin is able to do this by preventing the normal LDL from undergoing glycation and becoming MGmin-low-density lipoprotein.
Dr. Shannon Amoils who is a research advisor stated that this has taken the world a step further in understanding why so many people with type 2 Diabetes were at much greater risk of CHD. Now good measures are being taken to decrease if not eliminate this great risk.